Brought to you by:
New long-term data of paclitaxel devices continue to show no increased mortality compared to non-drug coated devices
New long-term data from the SAFE-PAD (Safety assessment of femoropopliteal endovascular treatment with paclitaxel-coated devices) study were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions (May 19–22) in Atlanta. The analysis…
Shockwave IVL maintains ‘superiority’ to angioplasty in calcified peripheral disease at two years
Shockwave Medical announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with intravascular lithotripsy (IVL) led to excellent long-term outcomes out to two years with preservation of future treatment options compared to percutaneous transluminal angioplasty (PTA)…
Tissue samples show paclitaxel effect in minority of CLTI patients receiving DCB angioplasty, study finds
Paclitaxel effect was witnessed in tissue specimens of a minority of chronic limb-threatening ischemia (CLTI) patients treated with drug-coated balloons (DCBs)—but was not dependent on DCB type, nor the dose level of the drug administered, and was not associated with…
Non-optimal therapy for CLTI ‘more prominent in females’
A real-world claims data analysis of nearly 200,000 patients with chronic limb-threatening ischemia (CLTI) showed that female patients were older, underwent vascular procedures less often, and received guideline-recommended drugs less frequently. However, it also highlighted that female sex was associated with better…
Venovo venous stent returns to US market after 2021 recall
BD recently announced that its Venovo venous stent is back on the U.S. market following a recall last year. In 2019, the company reported that the Food and Drug Administration (FDA) had granted premarket approval for the Venovo venous stent. In…
Cancer patients face greater risks from AAA repair
Elective abdominal aortic aneurysm (AAA) repair in patients with a cancer diagnosis is associated with several poor postoperative outcomes, according to a newly published study from researchers at the University of Missouri School of Medicine. “Due to the strong association between AAA and cancer,…
75th anniversary: Celebrate SVS history through photos
A week remains in the SVS Photo Contest, which celebrates the Society for Vascular Surgery’s 75th Anniversary. Members are sharing images that tell the Society’s collective story. The contest began in March and ends May 19. One winner and…
The top 10 most popular Vascular Specialist stories in April 2022
The digital version of the April 2022 issue of Vascular Specialist, the most recent editorial by our medical editor focusing on diversity within the vascular surgery workforce, and an interview chronicling the new age about to begin at the Journal…
Less frequent post-EVAR surveillance might be safe in some patient groups, study suggests
Results from the multicenter, retrospective ODYSSEUS study carried out in The Netherlands suggest that less frequent surveillance after endovascular aneurysm repair (EVAR) may be warranted. However, authors Anna C. M. Geraedts, MD, of Amsterdam University Medical Centres, Amsterdam, The Netherlands,…
War in Ukraine: A tale of unspeakable horror, unprecedented unity and unquenchable thirst for freedom
This editorial was written in the days leading up to April 2. At about 4 a.m. (Kyiv time) on Feb. 24, Russian President Vladimir Putin announced the start of a military operation aiming to “demilitarize and denazify Ukraine.” A few…